140 Followers on Owler
MyoKardia
is a biopharmaceutical company that develops and commercializes therapies for the treatment of cardiovascular diseases... Read moreMyoKardia
is a biopharmaceutical company that develops and commercializes therapies for the treatment of cardiovascular diseases... Read more
News
Aug 24, 2022
Owler
Myokardia, Inc.: MyoKardia's revenue changed from $46.96B in Mar 2022 to $47.16B in Jun 2022
Apr 13, 2021
Healthcare Weekly
MyoKardia: Bristol Myers Squibb Set to Acquire MyoKardia Heart Inc. Gaining Heart Drug Mavacamten In Deal
Jan 11, 2021
socalTECH
MyoKardia: Avidity Biosciences Swizzles Board
Jan 08, 2021
MarketScreener
MyoKardia: Avidity Biosciences : Announces 2021 Pipeline Updates and Research Collaboration with MyoKardia
Nov 19, 2020
Global Legal Chronicle
MyoKardia: Bristol-Myers Squibb Company's $7 Billion Notes Offering
Nov 18, 2020
Pharmafile
MyoKardia: Bristol Myers Squibb completes $13.1 billion acquisition of MyoKardia
Nov 15, 2020
Markets Insider
MyoKardia: MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten | Markets Insider
Nov 13, 2020
GlobeNewswire
Press Release: MyoKardia : MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association's Scientific Sessions 2020
Nov 11, 2020
BioSpace
MyoKardia: MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy
Nov 06, 2020
St Louis Post Dispatch
MyoKardia: MyoKardia: 3Q Earnings Snapshot
MyoKardia Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to MyoKardia?
MyoKardia News
MyoKardia Press Releases
MyoKardia Headquarters
MyoKardia Summary
ABOUT
Overview
MyoKardia is a biopharmaceutical company that develops and commercializes therapies for the treatment of cardiovascular diseases. MyoKardia was founded in 2012. MyoKardia's headquarters is located in Brisbane, California, USA 94005. MyoKardia's CEO, ...CEO
MyoKardia's CEO, Tassos Gianakakos, currently has an approval rating of 94%. MyoKardia's primary competitors are Tenaya, Cytokinetics, Five Prime and 17 more.Website
myokardia.comCompetitors
View 20 MyoKardia competitors here.Acquisitions
There have been no acquisitions found related to MyoKardiaInvestments
Recent investment data cannot be found related to MyoKardiaFrequently Asked Questions about MyoKardia
When was MyoKardia founded?
MyoKardia was founded in 2012Who is MyoKardia's CEO?
MyoKardia's CEO is Tassos GianakakosHow much revenue does MyoKardia generate?
MyoKardia generates $46.2B in revenueHow much funding does MyoKardia have?
MyoKardia has historically raised $114.4M in funding
Where is MyoKardia's headquarters?
MyoKardia's headquarters is in Brisbane California, USAHow many employees does MyoKardia have?
MyoKardia has 32,200 employeesWhat sector does MyoKardia operate in?
MyoKardia is in Biotechnology, PharmaceuticalsWho are MyoKardia's competitors?
MyoKardia's top competitors are Tenaya, Cytokinetics, Five Prime